Suppr超能文献

内肽酶-24.11抑制剂和C型心钠素受体配体对心房利钠肽诱发大鼠提睾肌小动脉反应的影响。

Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.

作者信息

Peyroux J, Beslot F, Claperon N, Fournie-Zaluski M C, Roques B P

机构信息

Laboratoire de Pharmacologie, U266 INSERM, UA 498, CNRS D. 1500, UFR des Sciences Pharmaceutiques et Biologiques, Paris, France.

出版信息

Br J Pharmacol. 1995 Dec;116(8):3117-24. doi: 10.1111/j.1476-5381.1995.tb15113.x.

Abstract
  1. The present study examined the effect of exogenous atrial natriuretric peptide (ANP), alone or in presence of inhibitors of the two major mechanisms for clearing ANP, metabolism by neutral endopeptidase-24.11 (NEP) and internalization by C-ANP receptors, on arteriolar responses using intravital microscopy on the rat cremaster muscle after intravenous or topical administration of the peptide. 2. Topical application of ANP (3 x 10(-10) to 3 x 10(-8) M) produced a gradual increase in arteriolar diameter. NEP inhibitors, thiorphan (30 mg kg-1, i.v.), kelatorphan (10 mg kg-1, i.v.) and retrothiorphan (25 mg kg-1, i.v.) alone, did not significantly affect vascular tone but caused significant potentiation of the arteriolar responses to topically applied ANP. 3. When given as an i.v. bolus, ANP dilates skeletal arterioles at a high dose (20 micrograms kg-1). At a lower dose (10 micrograms kg-2), ANP alone or with retrothiorphan or the C-ANP receptor ligand C-ANP (4-23) did not produce any arteriolar responses, while after the combined administration of the two inhibitors, an increase in arteriolar diameter was induced. 4. These results indicate that low doses of topically applied ANP dilate rat cremaster arterioles and that the vasodilator responses can be potentiated by NEP inhibition. When given as an i.v. bolus, a high dose of ANP can also dilate skeletal arterioles. However at a lower dose the rapid metabolism of the peptide prevents it from producing its action.
摘要
  1. 本研究通过在大鼠提睾肌上进行活体显微镜观察,静脉内或局部给予心房利钠肽(ANP)后,单独或在存在清除ANP的两种主要机制(中性内肽酶-24.11(NEP)代谢和C型ANP受体内化)抑制剂的情况下,研究了外源性ANP对小动脉反应的影响。2. 局部应用ANP(3×10⁻¹⁰至3×10⁻⁸ M)可使小动脉直径逐渐增加。NEP抑制剂,如硫肽素(30 mg kg⁻¹,静脉内注射)、凯托肽素(10 mg kg⁻¹,静脉内注射)和逆转硫肽素(25 mg kg⁻¹,静脉内注射)单独使用时,对血管张力没有显著影响,但可显著增强局部应用ANP时的小动脉反应。3. 静脉推注时,高剂量(20微克 kg⁻¹)的ANP可扩张骨骼肌小动脉。低剂量(10微克 kg⁻²)时,单独的ANP或与逆转硫肽素或C型ANP受体配体C-ANP(4-23)联合使用均未产生任何小动脉反应,而联合使用两种抑制剂后,可诱导小动脉直径增加。4. 这些结果表明,低剂量局部应用的ANP可扩张大鼠提睾肌小动脉,NEP抑制可增强血管舒张反应。静脉推注时,高剂量的ANP也可扩张骨骼肌小动脉。然而,低剂量时,该肽的快速代谢使其无法发挥作用。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/223412fa69d5/brjpharm00181-0045-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验